Effectiveness of clinical pharmacist intervention on medication adherence in patients with chronic obstructive pulmonary disease - A randomized controlled study

Patient Educ Couns. 2024 Jan:118:108037. doi: 10.1016/j.pec.2023.108037. Epub 2023 Oct 29.

Abstract

Objectives: In patients with chronic obstructive pulmonary disease (COPD), non-adherence remains challenging to achieve optimal disease control. Our study aimed to determine the impact of pharmacist-led educational interventions on COPD management, focusing mainly on medication adherence.

Methods: We conducted a 1-month open-labeled, randomized, controlled study at Ba Ria Hospital, Vietnam. COPD outpatients were randomly assigned to the intervention group or control group. Pharmacist-delivered education emphasized medication adherence, disease, and medication knowledge. The primary outcome was the between-group difference in medication adherence after the intervention, as assessed by the general medication adherence scale (GMAS).

Results: Of 181 recruited patients, 180 completed the follow-up. After the intervention, the results indicated a significant improvement in medication adherence rate between the two groups (90.1% vs. 66.3%, p < 0.001). Patient behavior was the most common barrier to non-adherence but was effectively reduced at the endpoint. The Modified Medical Research Council (mMRC) scale of dyspnea and inhalation technique also improved significantly in intervention patients.

Conclusions: Pharmacist intervention can considerably improve medication adherence and knowledge of COPD patients.

Practice implications: This study promotes the value of clinical pharmacists in patient education to achieve better adherence and enhance population health, especially in resource-limited nations like Vietnam.

Keywords: COPD; Medication adherence; Pharmacist intervention; Randomized controlled study; Vietnam.

Publication types

  • Randomized Controlled Trial

MeSH terms

  • Dyspnea
  • Humans
  • Medication Adherence
  • Outpatients
  • Pharmacists*
  • Pulmonary Disease, Chronic Obstructive* / drug therapy